USP22 knockdown or USP22 inhibition effectively promoted the sensitivity of HCC LR cells and primary HCC cells to lenvatinib (Fig. 7e and Supplementary Fig. 7c). The gene discussed is USP22; the disease is hepatocellular carcinoma.